By Dr. Priyom Bose, Ph.D.Jun 28 2023Reviewed by Lily Ramsey, LLM Research has shown that the Mediterranean diet is associated with a lower risk of breast cancer . However, the evidence of the impact of MD on BC survival remains inconclusive.
The survival rate depends on a number of factors, such as the patient's age, the stage of cancer, and so on. Advances in treatment and early detection are leading to an increased number of survivors. About the study The objective of the current study was to assess the association between adherence to the MD and all-cause and BC-specific mortality in women diagnosed with BC.
An arMED score of 0-5 was considered low adherence, 6-8 medium adherence, and 9-16 high adherence. To study the association between the arMED score and overall mortality, multivariable Cox proportional hazards models were estimated. For BC-specific mortality, Fine-Gray competing risk models were applied.
In Mediterranean countries, high adherence to MD appeared to be particularly beneficial against overall mortality.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
The value of pre-symptomatic genetic risk assessment for age-related macular degeneration: the Moran AMD Genetic Testing Assessment (MAGENTA) study—a study protocol for a randomized controlled trial - TrialsBackground Age-related macular degeneration (AMD) is an irreversible blinding eye condition with complex genetic and environmental etiologies. Genetic testing for AMD for previously identified multiple-risk single nucleotide polymorphisms can help determine an individual’s future susceptibility. However, such testing has been discouraged until evidence shows that providing such information to symptomatic or pre-symptomatic individuals will alter their disease course. Therefore, we designed this study to investigate whether knowledge of AMD risk could stimulate the adoption of a healthier lifestyle that could lower the incidence of AMD later in life. We hypothesize that pre-symptomatic individuals informed of a high genetic risk of AMD are more likely to make quantifiable, positive lifestyle changes relative to participants informed of lower genetic risk or randomized to deferred disclosure of genetic testing results. Methods The Moran AMD Genetic Testing Assessment (MAGENTA) study is a phase 2, single-center, prospective, double-masked, randomized controlled trial conducted at the John A. Moran Eye Center, University of Utah, Salt Lake City, Utah, USA. Participants are randomized by a 3:1 allocation ratio to immediate and deferred disclosure groups and followed for 12 months. Skin, ocular, and serum carotenoid status, as well as nutritional and social surveys, are assessed at study visits. Skin carotenoid assessment is by resonance Raman spectroscopy and reflectance spectroscopy, ocular carotenoids are measured with Heidelberg Spectralis autofluorescence imaging and fluorescence lifetime imaging ophthalmoscopy (FLIO), and serum carotenoids are quantified using high-performance liquid chromatography. The primary outcome evaluates changes in skin carotenoid status in response to genetic risk disclosure. The secondary outcomes examine changes in ocular and serum carotenoid status in response to genetic risk disclosure. Also, we will correlate AMD genetic risk with base
Source: BioMedCentral - 🏆 22. / 71 Read more »
Beyond expectations: study finds treatment success gap in drug-resistant TuberculosisBeyond expectations: study finds treatment success gap in drug-resistant Tuberculosis AarhusUni_int TB tuberculosis drugresistance successgap treatment therapy
Source: NewsMedical - 🏆 19. / 71 Read more »
Source: SkyNews - 🏆 35. / 67 Read more »